---
$id: https://graph.org.ai/products/commodity/51142419
$type: Product
source: UNSPSC
code: "51142419"
title: "Dotarizine"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dotarizine

**UNSPSC Code**: 51142419
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin antagonist and calcium channel blocker with the molecular formula C29H34N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IO7663S6D3, chemically known as 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine but generally known as dotarizine, which bears US NIH Compound Identifier 55285. European Medicines Agency schedules Dotarizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06378MIG. The term DOTARIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). DOTARIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dotarizine under HS 29349990 and SITC 51579. As of Q4 2014, DOTARIZINE remains the US FDA Preferred Term for this commodity. Dotarizine bears US NLM identifiers UMLS ID C0248284 and NCI Concept Code C77827. SMILES: O1C(OCC1)(CCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)C1CCCCC1.

